A study recently published in the journal Academic Radiology shows positive outcomes up to three years following treatment of uterine fibroids with MR-guided focused ultrasound.

In the study, 40 women with fibroids were treated with focused ultrasound. Researchers followed up with the women at three and six months, as well as one, two and three years. They found that the largest decrease in fibroid size occurred within the first six months and continued to happen over the three-year period.

 

The researchers also found that the women had significant symptom and quality-of-life improvements during the three-year follow-up period. In addition, there were no minor or major complications related to the treatment.

In the study, 69 percent of the women saw no need for additional treatment. Nine patients did obtain additional treatment – a hysterectomy, myomectomy or uterine artery embolization (UAE or UFE). Interestingly, this retreatment rate is comparable to longterm studies on UAE, a minimally invasive procedure that blocks the blood supply to the fibroids.

Kim, et al. MR-guided High intensity Focused Ultrasound Treatment for Symptomatic Uterine Leiomyomata: Longterm Outcomes. Academic Radiology, August 2011.

The Focused Ultrasound Foundation Newsletter

Our newsletter delivers updates for clinicians, researchers and patients. Sign up and stay on top of the rapid advancements of this innovative medical technology.

Sign Up  Read the Latest Issue

Read The Tumor  by John Grisham

From John Grisham, comes a story where today’s medical fiction could become tomorrow’s lifesaving reality.

Download a Free eBook or Audiobook

Contact Details

Call Us
434.220.4993
Find Us
Focused Ultrasound Foundation
1230 Cedars Court, Suite 206 Charlottesville, VA 22903
Email